bioRxiv · 10.1101/656785
Assessment of the in vitro function of human stem cell-derived β cells
Abstract
Insulin-producing human embryonic stem cell-derived {beta} (SC-{beta}) cells are a promising cell source for diabetes cell replacement therapy. We have recently reported a differentiation strategy that produces SC-{beta} cells in islet organoids that not only undergo glucose-stimulated insulin secretion but also have an islet-like dynamic insulin release profile, displaying both first and second phase insulin secretion. The goal of this study was to further characterize the functional profile of these SC-{beta} cells in vitro. We utilized a Seahorse extracellular flux analyzer to measure mitochondrial respiration of SC-{beta} cells at low and high glucose. We also used photolithography to fabricate a microfluidic device containing microwells to immobilize SC-{beta} cells for perfusional analysis, monitoring cytoplasmic calcium using Fluo-4 AM at low and high glucose. Here we find that in addition to increased insulin secretion, SC-{beta} cells have increased cellular respiration and cytoplasmic calcium ion concentration in response to a high glucose stimulation. Our results indicate that SC-{beta} cells have similar function to that reported for islets, providing further performance characterization that could help with eventual development for diabetes cell therapy and drug screening.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Srivatsava, A. R., Shahan, S. T., Gutgesell, L. C., Velazco-Cruz, L., Millman, J. R.. 2019-05-31. Assessment of the in vitro function of human stem cell-derived β cells. https://doi.org/10.1101/656785
Cite the original work for its findings. Save a collection to share your selection of sources.